Alvotech And Stada Make Biosimilars Pact
Stada Gains Rights To Seven Biosimilars In Europe And Beyond
Alvotech and Stada have struck a deal that will give Stada exclusive rights to sell seven Alvotech biosimilars “in all key European markets” as well as certain other territories.
